Written examinations Entry requirements We welcome students from all over the world and consider all applicants on an individual basis. Admissions Our minimum requirement is a 2.
The majority of these new companies are university spin-outs. The companies' main focus areas are very varied, but new cancer and cardiac therapies are perhaps the most prevalent.
Other areas range from inflammatory diseases, to bio-informatics, genomics and tissue engineering. The majority of the companies are focussed on new medical therapies, stemming from their origins in the medical schools in London. LBN's BioMapshows the biotechnology companies red dots mapped against the key research centres yellow dots in London.
It shows the companies are clustered close to the academic research centres in central London and also predominately towards the West of London. This to a large extent reflects the origins of biotechnology companies spinning out from the medical schools and universities of central London and migrating westwards as they grow.
London has a natural cluster of bioscience research within its medical schools, universities and hospitals - in fact probably the largest in Europe.
The spin out companies naturally like to remain geographically close to their academic centres, as they retain links as they grow.
These 3 universities have well-developed technology transfer companies who actively promote the commercialisation of research by forming spin-out companies or by the licensing of technology. London's biotech universities and their spin out companies Imperial College Medical School spins out more companies than any other university in Europe.
New companies are currently being spun out at a rate of two per month, the half of which are in biotechnology or healthcare related areas. Imperial opened an Entrepreneurship Centre in which apart from it's academic remit aims to enhance the entrepreneurial culture within Imperial College by providing students with the opportunity to explore entrepreneurial ideas and develop practical entrepreneurial skills.
University College London was one of the first universities in the UK to establish a unit dedicated to technology licensing and the creation of spin-out companies. University College London Ventures was founded in and is responsible for the management, protection and commercialisation of UCL's intellectual property.
UCLv has been increasingly involved in the creation of start-up companies. The School of Pharmacy, University of London have recently opened laboratories which house spin-out, Spirogen.
Another recent spin-out is PharMaterials. During February GET successfully completed a private placement to secure first round funding.
The company is developing cell based platform technologies that will be of great utility in the drug development and discovery processes. Value will be derived from the fact these systems will speed up these processes and allow identification and validation of drug candidates and novel drug targets that would not be identified using traditional methods.
The potential value of this approach is demonstrated by the fact that Xcellsyz has already made several significant deals to license its technology to major pharmaceutical companies including Glaxo SmithKline and Novo-Nordisk.
It is focused on the development of new vaccine technologies. It's mission is to become one of Europe's leading vaccine development companies by means of strategic alliances with vaccine manufacturers dedicated to the development of therapeutic vaccines against long term viral diseases.
Mature Biotechnology Companies London is also home to a group of older, and more established biotech companies which have out grown their incubator roots and are expanding rapidly, Arrow Therapeutics are one example of this.
Arrow Therapeutics Arrow span out of UCL in and is already making a significant contribution to anti-infective drug discovery.
This backing has allowed Arrow to develop and reap the benefits of a formidable platform of technologies that sets it apart from any of its competitors.
Arrow's essential gene discovery technology has recently been augmented by the acquisition of the best DNA array technology available together with licence agreements from Agilent, Rosetta and OGT covering their proprietary ink jet technology.
After three years in Surrey, Arrow moved in October to state of the art laboratories in central London. Despite the perception that London is difficult to exist in as a biotech company because of difficulties in finding suitable laboratory space and the price of land, Arrow moved back to London because it's Chief Executive Professor Ken Powell was convinced that London was the place in which he wanted to do business.
The key reasons for this included the ability to attract high calibre staff from the excellent universities and pharmaceutical companies in London and the South East, accessibility to visitors from home and abroad, proximity to the City and better value for money in terms of premises.
We couldn't claim that it was an easy exercise but it has certainly been well worth the effort. Another of London's successful biotech companies is Antisoma plc. Antisoma is a biopharmaceutical company focused on cancer drug development.
Established inAntisoma has in-licensed much of its intellectual property, including clinical development candidates pemtumomab formerly known as TheragynDMXAA and Therex, from cancer research and other academic institutions. Therex is completing a Phase I study in breast cancer and TheraFab has started a Phase 1 biodistribution study in non-small cell lung cancer.Science, Biotech & Pharmaceuticals Jobs in London Here is a selection of Science, Biotech & Pharmaceuticals jobs in London, United Kingdom 21 of jobs Search Science, Biotech & Pharmaceuticals jobs in London.
Biotechnology jobs in London (Greater). 7 jobs to view and apply for now with New Scientist Jobs. Your startup deserves a great name. Launch a naming contest. Get authentic name ideas for your startup from s of naming experts. Auto checked for URL & Trademark. I’ve spoken to the guys at Catapult in Guy’s college, who seem to be involved with some promising technologies.
MSc Biotechnology at UEL The programme offer a mix of traditional Biotechnology with an introduction to the cutting edge of research at the molecular level. The focus of the programme is not simply on the state of current knowledge but also the methodology used in obtaining that knowledge, making use of recent research papers to inform class .
London (Central), London (Greater) (GB) competitive salary and discretionary bonus, plus benefits including pension and health insurance; Intract Pharma; Intract Pharma seeks an enthusiastic and self-motivated biologics formulation specialist to drive its oral biologics development programmes.
Biotechnology in London, England. Innovation, research and invention are core to the business operations of companies in the biotechnology and life sciences industries.